Showing results (31-40 of 110) with videos related to

Sort By:
Pageof 11
Hormone Research|September 30, 2005
Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing's diseaseJ E Greening, C E Brain, L A Perry, et al.
British Journal of Cancer|November 2, 2013
Recognition of cancer warning signs and anticipated delay in help-seeking in a population sample of adults in the UKS L Quaife, L J L Forbes, A J Ramirez, et al.
Journal of Clinical Pathology|May 1, 1997
Girls with virilisation in childhood: a diagnostic protocol for investigationM E Street, A Weber, C Camacho-Hübner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Phase I and pharmacokinetic study of ecteinascidin-743, a new marine compound, administered as a 24-hour continuous infusion in patients with solid tumorsA Taamma, J L Misset, M Riofrio, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|June 15, 2010
Holistic management of DSDCaroline E Brain, Sarah M Creighton, Imran Mushtaq, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 23, 2022
Exposure of human immune cells, to the antiretrovirals efavirenz and lopinavir, leads to lower glucose uptake and altered bioenergetic cell profiles through interactions with SLC2A1Bethany J Heaton, Rebecca L Jensen, James Line, et al.
Clinical Endocrinology|April 1, 1989
The half-life of exogenous growth hormone after suppression of endogenous growth hormone secretion with somatostatinP C Hindmarsh, D R Matthews, C E Brain, et al.
Breast (Edinburgh, Scotland)|November 26, 2020
Real life efficacy of palbociclib and endocrine therapy in HR positive, HER2 negative advanced breast cancerB Porte, M Carton, F Lerebours, et al.
Journal of Cancer Research and Clinical Oncology|December 11, 1999
Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patientsP Soulié, C Garrino, M A Bensmaïne, et al.
Pageof 11